Related Experiment Video
Updated: Sep 24, 2025

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Retinal vessel changes in pulmonary arterial hypertension
Mariana DuPont1, Savanna Lambert2, Antonio Rodriguez-Martin3
1Department of Ophthalmology and Visual Sciences University of Alabama at Birmingham Birmingham Alabama USA.
Pulmonary arterial hypertension (PAH) is linked to increased retinal vascular tortuosity. These eye changes may help in early, noninvasive detection of this lung disease.
Area of Science:
- Ophthalmology
- Cardiology
- Pulmonology
Background:
- Pulmonary arterial hypertension (PAH) is primarily viewed as a lung vascular disease.
- Systemic effects of PAH are recognized but not fully understood.
- Retinal vascular changes in PAH patients are not well-documented.
Purpose of the Study:
- To investigate the presence and characteristics of retinal vascular changes in patients with pulmonary arterial hypertension (PAH).
- To explore the correlation between retinal vascular parameters and PAH disease severity.
- To assess the potential of retinal imaging for early PAH detection.
Main Methods:
- Retinal fluorescein angiography (FA) was performed on PAH subjects and controls.
- VESsel GENerational Analysis (VESGEN) software was used to analyze vessel branching and tortuosity.
- Clinical data on disease severity were collected for correlation analysis.
Main Results:
- PAH subjects showed significantly higher arterial and venous tortuosity compared to controls.
- Retinal tortuosity was most pronounced in PAH patients without connective tissue disease.
- Increased arterial tortuosity was observed in younger PAH patients, decreasing with age.
Conclusions:
- Pulmonary arterial hypertension is associated with increased retinal vascular tortuosity.
- Retinal vascular changes may serve as an indicator of pulmonary vascular disease progression.
- Fluorescein angiography combined with VESGEN analysis shows promise for noninvasive PAH detection.
More Related Videos
12:28Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies
Published on: March 12, 2022
10:11Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
Published on: October 22, 2014
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...